Commercial Opportunities

Partners with development and commercialisation expertise required

We are seeking partners with both development and commercialization expertise in cancer therapeutics, to assist in bringing our products into the market.

Help us to strengthen and expedite the development of clinical cancer products

The company develops products through to late stage clinical trials, using the CancerNav™ biomarker platform to guide the design of hypothesis-driven clinical trials. Celleron’s CancerNav™ platform identifies biomarkers that inform on tumour sensitivity patterns to new and existing drugs. Celleron wishes to leverage CancerNav™ by working with partner companies where the technology will strengthen and expedite the development of clinical cancer products. Celleron Therapeutics is interested in hearing about oncology products that respond favourably to the company's expertise in clinical and biomarker development. >> Contact us now

Invest in our unique products and technologies

Celleron Therapeutics is a product focussed privately held oncology business with a strong competitive advantage steming from the unique way in which CancerNav™ enables us to speed the develop of new cancer treatment products and improve the effectiveness of existing drugs. Our approach provides a cost efficient business model for the development of new treatments which ensures maximum use of investor and partner funds. We are interested in hearing from investors who are keen to support us in our ambitious plans. >> Contact us now